| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| TGF-beta 3 | Human TGF-beta 3 / TGFB3 Protein, premium grade | Human | HEK293 | ![]() | SDS-PAGE | $325.00 10ug | ||
| TGF-beta 3 | Human Latent TGF-beta 3 / Latent TGFB3 Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $345.00 50ug | ||
| TGF-beta 3 | Avitag TG3-H82E6 | Biotinylated Human Latent TGF-beta 3 / Latent TGFB3 Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 20ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Dalutrafusp alfa | GS-1423; AGEN-1423 | Phase 2 Clinical | Agenus Inc | Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours | Details |
| RG-6315 | RG-6315 | Phase 1 Clinical | Genentech Inc | Scleroderma, Systemic | Details |
| BMS-986416 | BMS-986416; AVID-200 DP; AVID-200 | Phase 1 Clinical | Formation Biologics Corp | Polycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Solid tumours; Thrombocythemia, Essential | Details |